1. HBW Insight
  2. >>Beauty
  3. >>Policy & Regulation
  4. >>Regulation

Sunscreen Consortium Breakdown Puts Future Of UV Filters In Doubt

 
• By Lauren Nardella

Efforts to unite as an industry to provide the US Food and Drug Administration with data to fill safety gaps for “chemical” UV filters have fizzled as the agency insists on animal-test requirements. Without a collaborative effort to share resources and costs, the long-marketed sunscreen actives may not receive the investment needed to demonstrate GRASE, and the US market may decay further in comparison with the diversity of modern sun-protection options available to consumers abroad.

Questions abound following the dissolution of the PCPC Sunscreen Consortium • Source: Shutterstock (Shutterstock)

An industry collaborative comprising more than 20 sunscreen product manufacturers and ingredient suppliers is no longer working to fulfill data needs identified by the US Food and Drug Administration for seven sunscreen UV filters currently on the market due to concerns over agency requirements for animal-based tests to support safety.

What that means for the future of those sunscreen active drug ingredients and the sunscreen products category in the US...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation

FDA’s FY 2026 Budget Request Lacks New Policy Proposals

 
• By Sue Sutter

The White House requested $6.8bn for the FDA, down 3.9% from the current funding level, but does not propose any legislative changes. In previous years, the agency used the budget process to seek statutory fixes specific to generic drugs and shortages.

House Appropriators’ $3.2Bn For FDA In FY 2026 Includes More Non-User Fee Funds Than Requested

 
• By Sue Sutter and Derrick Gingery

A US House bill would give the FDA $33.1m more in budget authority than requested by the Trump Administration for fiscal year 2026. The measure was sent to the full House Appropriations committee on a party-line vote.

IBA Interactive Policy Map Is Call To Action As Cosmetics Industry Braces For Myriad Of State Bills

 
• By Eileen Francis

The Independent Beauty Association has launched an interactive Policy Map tracking state and federal bills and filtering by state or topic, pinpointing bills of great priority.